Quercetin abrogates chemoresistance in melanoma cells by modulating ΔNp73

BACKGROUND: The alkylating agent Dacarbazine (DTIC) has been used in the treatment of melanoma for decades, but when used as a monotherapy for cancer only moderate response rates are achieved. Recently, the clinical use of Temozolomide (TMZ) has become the more commonly used analog of DTIC-related o...

詳細記述

保存先:
書誌詳細
主要な著者: Thangasamy, Thilakavathy, Sittadjody, Sivanandane, Mitchell, Geoffrey C, Mendoza, Erin E, Radhakrishnan, Vijayababu M, Limesand, Kirsten H, Burd, Randy
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2010
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2895613/
https://ncbi.nlm.nih.gov/pubmed/20540768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-10-282
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料